Transparency Market Research has published a new report titled, ‘Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
Transparency Market Research (TMR) has published a new report titled, ‘Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the global clinical laboratory services market was valued at US$ 232.6 Bn in 2018 and is projected to expand at a CAGR of 6.3% from 2019 to 2027.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=414
Overview
- Clinical laboratory is the place where the tests are performed on the clinical specimen so as to obtain health related information
- Clinical laboratories are the first step of disease diagnosis and treatment, which aids physicians in determining the root cause of a disease/condition and subsequently provide appropriate treatment
- North America dominated the global clinical laboratory services market in 2018 and the trend is anticipated to continue during the forecast period. High prevalence of different types of cancer and rising geriatric population in the region are some of the factors augmenting the market in North America
- Asia Pacific is likely to be a highly lucrative market for clinical laboratory services and it is expected to expand at a high CAGR during the forecast period
- High prevalence of infectious diseases and large population in developing countries of the region are some of the factors promoting growth of the market in APAC.
Request for Analysis of COVID-19 Impact on Clinical Laboratory Services Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=414
Surge in Incidence of Chronic and Infectious Disease to Drive Market
- Incidence of chronic and infectious diseases is anticipated to rise at an alarming rate during the forecast period
- Chronic diseases such as cardiovascular diseases, obesity, cancer, and diabetes are affecting several people worldwide
- The rise in these non-communicable chronic diseases is due to urbanization and adoption of unhealthy life styles. According to Centers of Disease control and Prevention (CDC) more than 60% of preventable deaths worldwide are caused due to non-communicable diseases
- In developing countries 48% of such deaths occur in persons above 70 years of age. The incidence of chronic diseases is also increasing rapidly in Africa
- Incidence of infectious diseases such as HIV, hepatitis, and other viral diseases has also been rising in the world
- World Health Organization (WHO) forecast that 13 million deaths would occur due to infectious diseases till 2050
- These factors have led to increasing demand for clinical laboratory testing, and are expected to drive the clinical laboratory services market from 2019 to 2027
Buy Clinical Laboratory Services Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=414<ype=S
Clinical Chemistry Segment to Dominate Market
- Based on test types, the global clinical laboratory services market has been divided into clinical chemistry, medical microbiology & cytology, food intolerance test human and tumor genetics, and other esoteric tests. The clinical chemistry segment dominated the global clinical laboratory services market in 2018 and the trend is projected to continue during the forecast period. Consistent demand as these are basic level tests for different physiological conditions and technological advancement in the tests such as adoption of protein mapping are the factors attributed to the growth of the segment.
Stand-alone Laboratories to be Highly Lucrative Segment
- In terms of service provider, the global clinical laboratory services market has been classified into stand-alone laboratories, hospital based laboratories, CROs, and others.
- The stand-alone laboratories segment dominated the clinical laboratory services market due to Increasing testing volumes and entry of new players.
- Additionally, rise in the number of public–private partnerships is expected to propel the segment during the forecast period.
Top of Form
Ask for Discount :
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=414
Competitive Landscape
- Key players in the global clinical laboratory services market include Charles River Laboratories International, Inc., OPKO Health, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare, Fresenius Medical Care Holdings, Inc. (Spectra), NeoGenomics Laboratories, Inc., Genomic Health, Inc., SYNLAB International GmbH, UNILABS, ARUP Laboratories, Eurofins Scientific, GENOPTIX, ALERE,INC., among others
Browse More Market Reports:
The global genotype assay market is expected to increase remarkably in the years to come due to the rise in occurrences of diseases that are genetically acquired all over the world. The measurement of genetic difference of a single nucleotide polymorphisms or SNPs across other members of a particular species is known as genotyping.There are different variations to the global genotyping assay market based on product and service, technology, application, and end-users. On the basis of product and services, the global market for genotyping assay is classified into reagents and kits, genotyping services, instruments, and bioinformatics. The instruments segment is further categorized into sequencers and amplifiers, and analyzers while the bioinformatics segment is further grouped into services and software. Among these, the reagents and kits segment holds a dominant share in the market as per the 2017 records.
Polycystic Kidney Disease Treatment Market:
Polycystic kidney disease (PKD) is a genetic disease that affects the kidneys and other organs by causing uncontrolled growth of cysts in the kidney, eventually leading to kidney failure. Cysts are filled with fluid that grow inside the kidneys, causing them to become enlarged and interfere with their ability to filter waste products from the blood. PKD can cause chronic kidney disease, which could lead to kidney failure or end-stage renal disease. The two primary types of PKD are autosomal dominant PKD and autosomal recessive PKD. These two forms of PKDs are distinguished by the usual age of onset and the pattern in which it is passed through families. According to the PKD Foundation, autosomal dominant polycystic kidney disease affects more than 600,000 people in the U.S. and 12.4 million people globally. Autosomal recessive polycystic kidney disease is a rare form of the disease that occurs in 1 in 20,000 children across the world.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453